A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder
PHASE3
Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
A Clinical Study That Will Assess the Effect of SEP-363856 or Prior Antipsychotic (PA) Standard of Care on Body-weight Associated Parameters in Subjects With Schizophrenia
PHASE1
A Clinical Study that will look at an investigational medication, SEP-36385...
A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
PHASE4
Digital medicine systems (DMS) have been designed to assist individuals wit...